IDiyas

For the Inventor, By the Inventor

Quincy, MA, United States of America

Ayako Honda

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 9.4

ph-index = 6

Forward Citations = 90(Granted Patents)


Location History:

  • Farmingdale, NY (US) (2009 - 2010)
  • Quincy, MA (US) (2010 - 2014)
  • Horsham, GB (2014)
  • Cambridge, MA (US) (2019 - 2021)

Company Filing History:

goldMedal10 out of 118 
 
Osi Pharmaceuticals, Inc.
 patents
silverMedal6 out of 3,923 
 
Novartis Ag
 patents

Years Active: 2009-2021

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 11066369 - N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease (2021-07-20),
2. 10450273 - N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their use in the treatment of disease (2019-10-22),
3. 8901147 - Bi-heteroaryl compounds as Vps34 inhibitors (2014-12-02),
4. 8796455 - Fused bicyclic mTOR inhibitors (2014-08-05),
5. 8735405 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors (2014-05-27),
6. 8685993 - Bi-heteroaryl compounds as Vps34 inhibitors (2014-04-01),
7. 8314148 - Selective hydroxamate based MMP inhibitors (2012-11-20),
8. 8314111 - Fused bicyclic motor inhibitors (2012-11-20),
9. 8232427 - Selective hydroxamate based MMP inhibitors (2012-07-31),
10. 8101613 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors (2012-01-24),
11. 7943767 - Fused bicyclic mTOR inhibitors (2011-05-17),
12. 7923555 - Fused bicyclic mTor inhibitors (2011-04-12),
13. 7820662 - 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors (2010-10-26),
14. 7700594 - Fused bicyclic mTOR inhibitors (2010-04-20),
15. 7696225 - (2-carboxamido)(3-Amino) thiophene compounds (2010-04-13),

Title: The Innovative Mind of Ayako Honda

Introduction

Ayako Honda, an accomplished inventor based in Quincy, MA, has made significant contributions to the field of pharmaceuticals with her groundbreaking inventions. With an impressive portfolio of 16 patents, she focuses on developing new compounds that hold the potential for transforming treatments for various diseases.

Latest Patents

One of Ayako's latest patents involves N-(pyridin-2-yl)pyridine-sulfonamide derivatives and their applications in treating diseases. This invention specifically addresses heterocyclic compounds capable of modulating the activity of the cystic fibrosis transmembrane conductance regulator (CFTR). Her work provides detailed methodologies for the synthesis of these compounds, emphasizing their therapeutic uses, particularly in managing disorders such as cystic fibrosis and related ailments.

Career Highlights

Throughout her career, Ayako has accumulated valuable experience in the pharmaceutical industry by working with prominent companies such as Osi Pharmaceuticals, Inc. and Novartis AG. Her expertise in the development of innovative treatments has positioned her as a leading figure in her field, showcasing her commitment to advancing medical science through her inventions.

Collaborations

Ayako Honda has collaborated with various industry professionals, including notable coworkers Andrew Philip Crew and Bijoy Panicker. These partnerships highlight her collaborative spirit and the dynamic environment in which she operates, further amplifying the impact of her innovative pursuits.

Conclusion

Ayako Honda's impressive array of patents and her dedication to advancing pharmaceutical innovations reflect her pioneering spirit. As she continues to develop new therapeutic solutions, her work remains a testament to the power of innovation in improving healthcare outcomes for many individuals affected by complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…